Effects of low-dose combined drospirenone-ethinylestradiol on perimenstrual symptoms experienced by women with endometriosis.

about

Effects of low-dose combined drospirenone-ethinylestradiol on perimenstrual symptoms experienced by women with endometriosis.

Item

http://www.wikidata.org/entity/Q47727181

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Effects of low-dose combined d ...... d by women with endometriosis.

@en

Effects of low-dose combined d ...... d by women with endometriosis.

@nl

type

Item

label

Effects of low-dose combined d ...... d by women with endometriosis.

@en

Effects of low-dose combined d ...... d by women with endometriosis.

@nl

prefLabel

Effects of low-dose combined d ...... d by women with endometriosis.

@en

Effects of low-dose combined d ...... d by women with endometriosis.

@nl

P1476

Effects of low-dose combined d ...... ed by women with endometriosis

@en

P2093

Akemi Koshiba

http://www.w3.org/2001/XMLSchema#string

Fumitake Ito

http://www.w3.org/2001/XMLSchema#string

Izumi Kusuki

http://www.w3.org/2001/XMLSchema#string

Taisuke Mori

http://www.w3.org/2001/XMLSchema#string

Yukiko Tanaka

http://www.w3.org/2001/XMLSchema#string

P2860

Dysmenorrhea: evaluation with cine-mode-display MR imaging--initial experience.

Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial.

Drospirenone, a progestogen with antimineralocorticoid properties: a short review.

Chronic pelvic pain in women: etiology, pathogenesis and diagnostic approach.

A new oral contraceptive regimen for endometriosis management: preliminary experience with 24/4-day drospirenone/ethinylestradiol 3 mg/20 mcg.

Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy women: a randomized, single-blind, parallel-group, multicentre study.

Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 microg ethinylestradiol.

Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 microg and ethinylestradiol 15 microg (Minesse).

A comparison of cycle control and effect on well-being of monophasic gestodene-, triphasic gestodene- and monophasic desogestrel-containing oral contraceptives. Gestodene Study Group.

The development of a menstrual distress questionnaire.

P304

135-139

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IJGO.2016.05.004

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

135

http://www.w3.org/2001/XMLSchema#string

P50

Jo Kitawaki

P577

2016-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27477035

http://www.w3.org/2001/XMLSchema#string

P921

endometriosis